6 results
Pathophysiology of Diabetic Ketoacidosis (DKA) and Hyperglycemic Hyperosmolar Syndrome (HHS)
Absolute Insulin deficit:
 - Type I DM:
Pathophysiology ... of Diabetic Ketoacidosis ... #dka #hhs #pathophysiology ... #comparison #endocrinology ... #diabetes #diabetic
The “twin cycles” of diabetes, first introduced by Roy Taylor in 2008.  
#fatty liver #fatty
twin cycles” of diabetes ... pancreas #diabetes ... #t2d #dm2 #insulin ... resistance #pathophysiology ... #endocrinology
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... Summary Table Insulin ... EricsMedicalLectures/featured #diabetes ... #management #endocrinology ... #dm2
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Diabetes Mellitus ... in Type 1 Diabetes ... monitors in Type 1 Diabetes ... pocketcardset #Diabetes ... #Mellitus #DM2
Diabetic Ketoacidosis (DKA) - Pathogenesis and Clinical Findings
 • Note: in DKA, body K+ is lost
Diabetic Ketoacidosis ... patient has good renal ... DiabeticKetoacidosis #DKA #pathophysiology ... #endocrinology ... #diabetes
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
-> Stimulates Insulin ... will stimulate insulin ... patients have renal ... Pharmacology #Management #Diabetes ... #DM2 #Endocrinology